ReviewCancer management and research2023

Profile of Nivolumab in the Treatment of Resected Esophageal Squamous Cell Carcinoma: A Review of the Clinical Data.

Yuntae Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.